The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.
Sunshine Data Released – What’s Next?
On September 30 at
around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly
released the data that it had been gathering from pharmaceutical and medical
device companies that detail value transfers to physicians and medical schools. ASH has been keeping members apprised of
these developments since this provision was included in the Affordable Care
Least Costly Alternatives for Drugs in the World of Hematology
The Medicare Payment
Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to
take on an issue that could be very important for hematologists and access to
drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis. ASH continues to
follow this issue as part of a commitment to ensure that policies are created
that give patients efficient access to important drugs while maintaining
clinician decision-making and incentives for continued innovation.
Medicaid Pay Parity Nears Expiration – ASH Works with ACP to Extend
the passage of the ACA, specialists in internal medicine—including hematologists—have
been eligible for increased Medicaid payment rates. The ACA, however, limited this increase in
payment to 2013 and 1014, and the rates will soon revert to their former levels
without further legislation. ASH has
worked with the American College of Physicians and other stakeholders to
support legislation that would extend this payment parity, and has recently
submitted a letter to further show support.